Technology evaluation: AAV factor IX gene therapy, Avigen Inc

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	601-6
Number of pages	6
Journal	Current opinion in molecular therapeutics
Volume	2
Issue number	5
Publication status	Published - 2000

Keywords

@article{791d3d2ee2aa474c85d686bf58d6e0b3,

title = "Technology evaluation: AAV factor IX gene therapy, Avigen Inc",

keywords = "Animals, Antibody Formation, Biotechnology, Dependovirus, Factor IX, Gene Therapy, Genetic Vectors, Hemophilia B, Humans, Male",

author = "Fabb, {S A} and Dickson, {J G}",

year = "2000",

language = "English",

volume = "2",

pages = "601--6",

journal = "Current opinion in molecular therapeutics",

issn = "1464-8431",

publisher = "Current Drugs Ltd.",

number = "5",

}

TY - JOUR

T1 - Technology evaluation: AAV factor IX gene therapy, Avigen Inc

AU - Fabb, S A

AU - Dickson, J G

PY - 2000

Y1 - 2000

KW - Animals

KW - Antibody Formation

KW - Biotechnology

KW - Dependovirus

KW - Factor IX

KW - Gene Therapy

KW - Genetic Vectors

KW - Hemophilia B

KW - Humans

KW - Male

M3 - Article

C2 - 11249763

SN - 1464-8431

VL - 2

SP - 601

EP - 606

JO - Current opinion in molecular therapeutics

JF - Current opinion in molecular therapeutics

IS - 5

ER -